Patrick Quinn
Associate Professor
Email: quinnp@iu.edu
Phone: 812-855-9789
Address: 809 E. 9th St.
Department: Applied Health Science
ORCID - 0000-0002-6770-8762
PhD (Clinical Psychology), The University of Texas at Austin, 2014
APA-Accredited Pre-Doctoral Clinical Psychology Internship, Indiana University School of Medicine, 2013–2014
MA, The University of Texas at Austin, 2011
BA, Swarthmore College, 2005
Selected Grants/Awards
- 2025-2030: Multiple Principal Investigator, Integrative predoctoral training in drug abuse research at Indiana University (NIH/NIDA, #T32DA024628)
Scholarly Interests
Dr. Quinn studies the biopsychosocial causes and health consequences of substance use. His team conducts research on a range of substances, from alcohol and cigarettes to opioids and prescribed stimulants. This work also ranges across the lifespan, assessing prenatal drug exposure, adolescent substance use, and medication treatments in adults. Much of Dr. Quinn’s current research examines pain and its treatment with opioid medications, using longitudinal health and healthcare data on individuals and families. As a licensed psychologist, Dr. Quinn is also interested in suicide prevention and other topics in mental health.
- Sepe-Forrest, L., Meraz, R., Adams, S. M., D’Onofrio, B. M., & Quinn, P. D. (2025). Diagnostic patterns and racial/ethnic differences in antipsychotic prescribing among privately insured youth. Translational Issues in Psychological Science. Advance online publication. https://doi.org/10.1037/tps0000457
- Summit, A. G., Moseley, M. C., Chaku, N. Elam, K. K., Jacobs, W., Lederer, A. M., Vaughan, E. L., & Quinn, P. D. (2025). Prevalence of pharmacotherapy for ADHD and prescription stimulant misuse: A national study of US college students. Addiction, 120, 721-731.
- Chen, C., Pettersson, E., Summit, A. G., Boersma, K., Chang, Z., Kuja-Halkola, R., Lichtenstein, P., & Quinn, P. D. (2023). Chronic pain conditions and risk of suicidal behavior: A 10-year longitudinal co-twin control study. BMC Medicine, 21, 9.
- Quinn, P. D., Chang, Z., Bair, M. J., Rickert, M. E., Gibbons, R. D., Kroenke, K., & D’Onofrio, B. M. (2022). Associations of opioid prescription dose and discontinuation with risk of substance-related morbidity in long-term opioid therapy. PAIN, 163, e588-e595.
- Quinn, P. D., Fine, K. L., Rickert, M. E., Sujan, A. C., Boersma, K., Chang, Z., Franck, J., Lichtenstein, P., Larsson, H., & D'Onofrio, B. M. (2020). Association of opioid prescription initiation during adolescence and young adulthood with subsequent substance-related morbidity. JAMA Pediatrics, 174, 1048-1055.
- Sujan, A. C., Quinn, P. D., Rickert, M. E., Wiggs, K. K., Lichtenstein, P., Larsson, H., Almqvist, C., Öberg, A. S., & D'Onofrio, B. M. (2019). Maternal prescribed opioid analgesic use during pregnancy and risk for adverse birth outcomes: A population-based study. PLOS Medicine, 16, e1002980.
- Quinn, P. D., Chang, Z., Hur, K., Gibbons, R. D., Lahey, B. B., Rickert, M. E., Sjölander, A., Lichtenstein, P., Larsson, H., & D’Onofrio, B. M. (2017). ADHD medication and substance-related problems. American Journal of Psychiatry, 174, 877-885.
- Quinn, P. D., Rickert, M. E., Weibull, C. E., Johansson, A. L. V., Lichtenstein, P., Almqvist, C., Larsson, H., Iliadou, A. N., & D’Onofrio, B. M. (2017). Association between maternal smoking during pregnancy and severe mental illness in offspring. JAMA Psychiatry, 74, 589-596.